FGF23 and Cowden syndrome 1: A prior small study found that in patients with AMI complicated by CS without apparent pre-existing CKD FGF-23 levels were profoundly increased, showing more than 10-fold higher FGF-23 levels in patients with CS compared to patients with stable coronary artery disease (CAD).